Dr John Atherton is Director of Cardiology, Royal Brisbane and Women’s Hospital, Associate Professor, University of Queensland, and Adjunct Professor, Queensland University of Technology.
Dr Atherton was on Board of the Cardiac Society of Australia and New Zealand (CSANZ) during 2009–2015 and chairs the CSANZ Professional Ethics Standards Committee. Dr Atherton previously chaired the Asia-Pacific Acute Decompensated Heart Failure Registry Scientific Advisory Committee and the CSANZ Heart Failure Council. Dr Atherton is an appointed member of the Australian Government Medical Services Advisory Committee and provides advice to Government on public funding arrangements through Medicare.
Dr Atherton is Associate Editor, Heart Lung and Circulation, and sits on the editorial board for Cardiac Failure Review. Research interests include screening for presymptomatic heart disease and heart failure disease management. Contributions to service enhancement include the development of coordinated statewide heart failure disease management in Queensland, and commencing a statewide cardiac genetics clinic.
Cardiac Failure Review 2017;3(1):25–32.
Should Angiotensin Receptor Neprilysin Inhibitors Replace Angiotensin-converting Enzyme Inhibitors...
Cardiac Failure Review 2016;2(1):47–50